Skip to content

New $7 million research initiative to help tackle early-onset cancer

By API User

The Albanese Government has launched the Cancer Australia Research Initiative (CARI), a bold new program aimed at addressing emerging needs in cancer research. The program commits $7 million over three years to fund research into early-onset cancers. Early-onset cancer refers to cancers that are diagnosed in younger adults, typically between the ages of 20 and 49. … Continued

‘Nothing in town other than us’: rural pharmacists’ role in oral health

By API User

Pharmacists are stepping in as frontline providers of oral healthcare advice in rural Victorian towns without dental practitioners, offering oral hygiene advice, managing dental pain inquiries and promoting preventative care, according to a new study by La Trobe University. Eleven rural pharmacists shouldering health responsibilities far beyond traditional dispensing roles participated in the study, which … Continued

TGA APPROVES LIFE SAVING TECHNOLOGY FOR PREGNANT WOMEN WITH TYPE 1 DIABETES

By API User

*** VIDEO/AUDIO grabs available here Australia should follow the UK’s lead in supporting mums-to-be with Type 1 diabetes, said leading health technology developer Ypsomed, to ensure the best possible health outcomes for pregnant women and their babies.   In an Australian first, the Therapeutic Goods Administration (TGA) has approved the Ypsomed mylife Loop system for use … Continued

Vaping more effective at helping socially disadvantaged people quit smoking compared to nicotine gum or lozenges, major clinical trial shows

By API User

Vapes containing nicotine are a more effective quit-smoking aid than nicotine lozenges and gum among adults experiencing social disadvantage, who typically have a harder time quitting than others, according to results from a landmark clinical trial. Australia has one of the lowest smoking rates globally – currently, 8.8% of adults are daily smokers – however, … Continued

Antinausea medication linked to higher survival rates in women with triple negative breast cancer

By API User

A new study has found a commonly prescribed anti-nausea medication is associated with better prognosis for women with early-stage breast cancer, particularly triple negative breast cancer.   The research team, co-led by Monash University and the Norwegian Institute of Public Health, evaluated Cancer Registry of Norway data of 13,811 women diagnosed with early-stage breast cancer … Continued